Evonik's Political Headwind and Partner-Led Pipeline Keep Two Valuation Stories Running in Parallel

North Rhine-Westphalia's economy minister, Mona Neubaur, came out against a BASF takeover of Evonik on 14 October — a political signal that puts jobs and the German industrial base alongside price in the debate over the specialty chemicals maker. Investors now have to weigh offer terms against regional interests, though the minister's stance is a long way from a binding decision on any transaction.

The same day, the state parliament rejected an SPD motion to examine whether North Rhine-Westphalia should take a stake in Evonik. The two positions are distinct: opposing a BASF deal does not amount to backing a state investment, and the rejection of the motion should not be read as support for one.

Concessions Reported, but Nothing Signed

Two days before Neubaur's intervention, media reports — citing two people close to the company — said BASF would be prepared to guarantee jobs through 2032 and keep the German site in the event of a takeover. BASF declined to comment. That reported willingness is not a confirmed agreement: site pledges may ease political concerns, but they settle neither the purchase price nor a binding takeover contract.

Separately, dpa-AFX reported last week, citing circles, that BASF is open to considering a higher bid — conditional on first gaining access to Evonik's books. Evonik turned down BASF's initial offer of EUR 22.15 per share, so any improvement remains tied to that precondition.

A Product Launch and a Japanese Recycling Pact

Away from the takeover saga, Evonik has been busy on the operating side. On Monday the group launched Lypron, a rumen-stable lysine solution designed for targeted amino acid supply in ruminants; French specialist Sipena will manufacture it exclusively for Evonik. According to the company, Lypron complements its amino acid balancing concept.

Then, on 13 October, Evonik agreed a recycling initiative in Japan with Toyotsu Chemiplas and Sanyo Chemical Industries. The roles are split: Toyotsu Chemiplas coordinates collection and logistics, Sanyo Chemical contributes polyol development and process engineering, and Evonik supplies its hydrolysis recycling technology. The goal is to recover polyols and amines from polyurethane foam for use in new polyurethane products.

The two projects differ in maturity — Lypron is already on the market, while the Japanese effort is a joint development agreement — so they are not equivalent operational milestones. Both, however, point to product development and partnerships rather than to the takeover question, and neither allows any conclusion about future earnings contribution.

What Investors Should Watch Next

For shareholders, the two threads need to be kept apart. The partnerships concern the operating trajectory; the takeover question hinges on price, conditions and whether the parties can reach an understanding. Political resistance is a relevant factor, but not a final verdict on the outcome.

The next scheduled financial date is 3 November, when Evonik publishes its interim report for the third quarter of 2026 — the nearest fixed point for assessing the business on the numbers.